Sophie Balzora in New York, New York

Home New York New York

Sophie Balzora has Gastroenterology as her primary medical specialty. Their primary office is: 111 Broadway in New York, New York. There are 7 additional office locations for Sophie Balzora that can be viewed towards the end of their profile.

They're a part of the: New York University medical group which has around 4,291 members. You can call their office at 212-263-9700 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended George Washington University School Of Medicine and graduated in 2006 (around 18 years of experience). They are listed as doing telehealth appointments.

Sophie M Balzora Office Phone and Directions

Sophie Balzora
New York University
111 Broadway
New York, New York 10006
212-263-9700

Patient Ratings
Please rate your experience with Sophie Balzora below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 212-263-9700

Enter a starting address:

Healthcare Info for Sophie Balzora

Medical School: George Washington University School Of Medicine
Graduation Year: 2006
The Primary Medical Specialty for Sophie Balzora is listed as: Gastroenterology
Approximate Years of Experience: 18
PAC (PECOS ID)#: 1456517168
NPI #: 1487813994
NPI Created On: 06/09/2008
NPI Last Updated Listed as: 02/23/2021
Primary Taxonomy Code: 207RG0100X
License Number:
249923
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope
Biopsy of large bowel using an endoscope
Removal of polyps or growths of large bowel using an endoscope
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $167

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788309679

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Immunology

Name of Drug #1: STELARA

Open Associated Drug #1: 57894-060-03

Payments Total: $30

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793976523

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: HUMIRA

Open Associated Drug #1: 0074-0554-02

Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793976527

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: HUMIRA

Open Associated Drug #1: 0074-0554-02

Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 819858665

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: INTERNAL MEDICINE

Name of Drug #1: GATTEX

Open Associated Drug #1: 68875-0101-2

Payments Total: $6,050

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 833388217

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT

Name of Drug #1: XELJANZ

Open Associated Drug #1: 0069-1001-01

Payments Total: $9,075

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 833388219

Being Disputed:: No

Product Related: No

Payments Total: $3,300

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 833388221

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT

Name of Drug #1: XELJANZ

Open Associated Drug #1: 0069-1001-01

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 850128591

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Gastroenterology

Name of Drug #1: XIFAXAN

Open Associated Drug #1: 65649-303-02

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 850384275

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Gastroenterology

Name of Drug #1: XIFAXAN

Open Associated Drug #1: 65649-303-02